Ipsen Biopharmaceuticals, Inc.
Ipsen Biopharmaceuticals, Inc. is the U.S. affiliate of Ipsen (Euronext: IPN; ADR: IPSEY), a global biopharmaceutical group focused on innovation and specialty care. The company is dedicated to providing hope for patients whose lives are challenged by difficult-to-treat diseases, focusing its resources, investments and energy on discovering, developing and commercializing new therapeutic options in oncology, neurosciences and rare diseases. For more information on Ipsen in North America, please visit www.ipsenus.com.